Minimizing Pregnancy/Postpartum Relapses: A Clinical Perspective

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Disease reactivation during and after pregnancy is a challenge facing many women with MS and their clinicians. How can relapses be prevented? What are the benefits of pregnancy planning? What are the risk factors for postpartum MS reactivation? How can they be modified? 

These are the questions Dr. Kristen Krysko from the University of California San Francisco addresses in this eMultipleSclerosis Review podcast.  

UPDATE 6/26/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Paul Auwaerter interviews Dr. Kathleen Page about the impact COVID-19 has had on minority populations.

  • Why have minority populations been more affected by COVID-19?
  • The impact of comorbidities
  • Public health messaging
  • The importance of trust and communication

UPDATE 6/10/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • Best methods of transmission prevention
  • Asymptomatic transmission – mixed messages
  • Survey results: messaging, trust, and ethnic impact
  • Therapeutics update
  • COVID-19 weakening?
  • Reopening schools
  • Blood type and risk of infection

UPDATE 6/5/2020 – COVID-19: Keeping Up With A Moving Target

Sue Hansen, MSN, RN discusses what we’ve learned from COVID-19 and lessons for the future:

  • Required training and support for staff
  • Infection prevention, control and testing
  • How to run a code blue 
  • Post-acute care, and
  • Performing non-emergent operations

UPDATE 6/3/2020 – COVID-19: Keeping Up With A Moving Target

Dr. Auwaerter updates us on COVID-19 and answers your questions. Topics covered:

  • Super spreader events
  • What is reproduction number (R0) and dispersion factor (k)?
  • Re-opening offices and churches
  • Herd immunity
  • COVID-19 causes of death
  • Vaccines in development

In the Clinic: Triple Combination CFTR Modulation

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Elexacaftor/tezacaftor/ivacaftor — the newly approved triple combination CFTR modulator therapy.  What are the benefits?  For which patients?  What are the potential adverse effects?  Who’s most likely to receive them?  

In this issue, Dr. Scott Sagel from the Breathing Institute at the Children’s Hospital Colorado, part of the University of Colorado’s Anschutz Medical Campus, takes us to the clinic to discuss some answers. 

UPDATE 5/29/2020 – COVID-19: Keeping Up With A Moving Target

In this update for clinicians caring for patients with COVID-19, Sue Hansen, MSN, RN discusses what we’ve learned from COVID-19 and lessons for the future:

  • Emergency planning
  • Capacity management
  • Supplies
  • Clinical course of COVID-19
  • PPE care at home
  • Nursing students return to hospitals